<DOC>
	<DOCNO>NCT00611403</DOCNO>
	<brief_summary>This study evaluate safety efficacy cyclosporine ophthalmic emulsion administer twice daily follow LASIK surgery</brief_summary>
	<brief_title>Safety Efficacy Study Cyclosporine Ophthalmic Emulsion Post-LASIK Patients</brief_title>
	<detailed_description />
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patient schedule bilateral LASIK surgery Patient good general health Eye glass prescription 1 8 Significant Dry Eye Presence eye disease Uncontrolled systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>LASIK</keyword>
</DOC>